Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks’ treatment in patients with clinically stable schizophrenia

  1. Lambert, M.
  2. Sanchez, P.
  3. Bergmans, P.
  4. Gopal, S.
  5. Mathews, M.
  6. Wooller, A.
  7. Pungor, K.
Revue:
Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Année de publication: 2020

Volumen: 16

Pages: 3197-3208

Type: Article

DOI: 10.2147/NDT.S286654 GOOGLE SCHOLAR lock_openAccès ouvert editor